Indication
Hypertrophic Obstructive
2 clinical trials
3 products
Product
MavacamtenClinical trial
A Phase 3, Open-label, Single Arm, Clinical Study to Evaluate Efficacy, Safety and Tolerability of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic CardiomyopathyStatus: Active (not recruiting), Estimated PCD: 2023-11-27
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Sequential, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic CardiomyopathyStatus: Terminated, Estimated PCD: 2022-11-22
Product
PlaceboProduct
CT-G20